Graham, good to see someone sticking to the science here. I have a few questions:
1. What other cell lines will the vector work on? I suspect they should at least already have nailed down Cos-7, but what is the timetable for the others?
2. What type of applications are we talking about here?
a) Anti-cancer, b) telomerase, c) antisense, d) all three
3. Has any patent yet been granted? Anyone can file a patent. And even if CYGS has excellent technology, without a patent being granted they run the risk of patent infringement. What they are doing is a very competitive thing, so without a patent, they have no leg to stand on, and as CYGS is betting the farm on this, no CYGS.
4. How close are they to any sort of clinical application?
5. When do they expect Dr. Conrad to finally publish on his research, and in what medical journal do they realistically hope to be accepted into? If CYGS truly does have something that will "rock the medical world", then I expect them to say Nature or Scientific American. At the very least, if the technology is "decent", I expect Cell.
- Jeff |
